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Abstract : Objective : An attempt was made to identify characteristic cytokine profiles to distinguish periodic fe-
ver with aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPAS) from recurrent tonsillitis, of 
which clinical manifestations are similar to those of PFAPAS in children. Methods : Serum concentrations of IL-
6, IL-4 and IFN-γ were measured during febrile episodes in pediatric patients. Results : The levels of IL-6 during 
febrile episodes were markedly increased above the upper limit of normal ranges in patients with both PFAPAS 
and recurrent tonsillitis, but there were no significant differences between groups. The levels of IL-4 during fe-
brile episodes in PFAPAS patients were significantly lower than those in recurrent tonsillitis patients. The levels 
of IFN-γ during febrile episodes in PFAPAS patients were significantly higher than those in recurrent tonsillitis 
patients. Conclusion : In pediatric patients with PFAPAS, despite an increase of IL-6, IL-4 was suppressed with 
a marked increase of IFN-γ during febrile episodes. On the contrary, in febrile pediatric patients with recurrent 
tonsillitis, both IL-6 and IL-4, but not IFN-γ were increased. The characteristic cytokine profiles of IL-6, IL-4 and 
IFN-γ can be used for differential diagnosis of PFAPAS from recurrent tonsillitis in children in clinical ear, nose 
and throat (ENT) settings. J. Med. Invest. 68 : 38-41, February, 2021
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INTRODUCTION
 
Periodic fever with aphthous stomatitis, pharyngitis and 
cervical adenitis (PFAPA) syndrome was first described by 
Marshall in 1987 (1) and is characterized by periodic episodes 
of high fever lasting 4 to 6 days and regularly recurring every 
3 to 5 weeks, which are accompanied with aphthous stomatitis, 
pharyngitis and cervical adenitis (2). PFAPA syndrome is an 
autoinflammatory disease that develops before age 5 in most 
patients, but the responsible gene has yet to be identified (3). Be-
cause PFAPA syndrome is diagnosed by exclusion for lack of spe-
cific biomarkers, cardinal signs and symptoms must be carefully 
observed for a differential diagnosis. But, otolaryngologists may 
not usually suspect PFAPA syndrome when treating children 
with a history of periodic fever. Especially, because patients with 
PFAPA syndrome show either tonsillar erythema or white spots 
on the tonsils with cervical adenitis in addition to elevated levels 
of white blood cell (WBC) and C-reactive protein (CRP) during 
febrile episodes (4, 5), these clinical findings lead to misdiagno-
sis of recurrent tonsillitis, of which clinical manifestations are 
similar to those of PFAPA syndrome in children. Consequently, 
the misdiagnosed patients would receive unnecessary antibac-
terial therapy and their diagnosis of PFAPA syndrome might 
be delayed. 
Recently, it was reported that in patients with PFAPA syn-
drome, inflammatory cytokines such as IL-6, IFN-γ, IL-1β and 
TNF-α but not IL-4 were elevated during febrile episodes (6). 
However, it was also reported that levels of IL-1β and TNF-α 
reached a peak early in febrile episodes and quickly return to 
normal levels in patients with PFAPA syndrome before hospital 
visit (5, 7). Moreover, IL-6 is commonly elevated in many in-
flammatory diseases and may not confirm a diagnosis of PFAPA 
syndrome alone. In the present study, an attempt was made to 
identify characteristic cytokine profiles to distinguish PFAPA 
syndrome from recurrent tonsillitis in children in clinical ENT 
settings. For this purpose, we measured the serum levels of IL-6, 
IL-4 and IFN-γ in pediatric patients with PFAPA syndrome 
during an episode of high fever, and compared to those in pediat-
ric patients with recurrent tonsillitis during high fever. 
SUBJECTS AND METHODS
Subjects
Three patients with PFAPA (One male and 2 females, mean 
age : 5.2 ± 0.2 years old) who met the diagnosis criteria proposed 
by Thomas et al. (8), Padeh et al. (9) and Gattorno et al. (10), and 
4 patients with recurrent tonsillitis (One male and 3 females, 
mean age : 11.5 ± 7.6 years old) which was diagnosed by otolar-
yngologists were included in the present study. 
This study was approved by the Committees for Medical Eth-
ics of Tokushima University Hospital and National Kochi Hos-
pital. Written informed consent was obtained from a parent of 
each child with recurrent tonsillitis prior to blood sampling. The 
retrospective chart review of patients with PFAPA syndrome 
was also performed. 
Methods
Serum samples were collected during febrile episodes from 
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each patients and serum concentrations of IL-6, IL-4 and IFN-γ 
were measured by SRL Co. Ltd., Japan. White blood cell counts 
and CRP in the serum were also measured at the hospital labo-
ratory. One to 4 days after the onset of a typical febrile episode, 
blood samples were taken from patients with PFAPA, and 2 
to 3 days after the onset of high fever, blood samples were also 
taken from patients with recurrent tonsillitis. Neither systemic 
steroid nor non-steroid anti-inflammatory drug were given to the 
patients in both groups before blood samples had been taken at 
hospital visit. 
Statistical analysis 
Comparisons between groups were analyzed by Welch’s t-test. 
P-values of < 0.05 were considered statistically significant, and 
all statistical analyses were performed using Statcel 3 (OMS 
Publishing Inc, Saitama, Japan).
RESULTS
The clinical characteristics of the pediatric patients with 
PFAPA and recurrent tonsillitis are shown in Table 1. There 
were no significant differences in gender, age, sampling day 
after the onset of fever, maximal temperature, WBC counts or 
levels of CRP between groups. The mean serum levels of IL-6 
during febrile episodes in patients with both PFAPA syndrome 
(33.8 ± 5.6 pg / ml) and recurrent tonsillitis (46.4 ± 18.8 pg / ml) 
were markedly increased above the upper limit of normal rang-
es, but there were no significant differences between groups 
(Fig. 1). The mean serum levels of IL-4 during febrile episodes 
in patients with recurrent tonsillitis (7.8 ± 1.5 pg / ml) were sig-
nificantly higher than those in patients with PFAPA syndrome 
(3.0 ± 0.4 pg / ml) (Fig. 2). The mean serum levels of IFN-γ during 
febrile episodes were markedly increased above the upper limit 
of normal ranges in patients with PFAPA syndrome (319.0 ± 18.3 
IU / ml) and significantly higher than those in patients with re-
current tonsillitis (1.02 ± 0.72 IU / ml) (Fig. 3). 
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Table 1.　Clinical characteristics of pediatric patients with PFAPA 
and recurrent tonsillitis
PFAPA 
syndrome
(n = 3)
Recurrent  
tonsillitis 
(n = 4)
Gender (Male : Female) 1 : 2 1 : 3
Age (years old) 5.2 ± 0.2 11.5 ± 7.6
Sampling day after the onset of fever 2.3 (1-4) 2.5 (2-3)
Maximal temperature (℃) 39.4 39.5
WBC at sampling (counts / mm3) 10977 13015
CRP at sampling  (mg / dl) 3.13 4.48
WBC : white blood cell, CRP : C-reactive protein. 
Fig. 1.　Levels of IL-6 in the blood during febrile episodes in pediatric 
patients with PFAPA syndrome and recurrent tonsillitis. Columns 
and bars represent means ± S.E. PFAPA syndrome : n = 3, recurrent 
tonsillitis : n = 4. N.S. : not significant. Dashed bar means the upper 
limit of normal ranges (4.0 pg / ml).
Fig. 2.　Levels of IL-4 in the blood during febrile episodes in pediatric 
patients with PFAPA syndrome and recurrent tonsillitis. Columns 
and bars represent means ± S.E. PFAPA syndrome : n = 3, recurrent 
tonsillitis : n = 4. *p < 0.05. Dashed bar means the upper limit of 
normal ranges (5.0 pg / ml).
Fig. 3.　Levels of IFN-γ in the blood during febrile episodes in 
pediatric patients with PFAPA syndrome and recurrent tonsillitis. 
Columns and bars represent means ± S.E. PFAPA syndrome : n = 3, 
recurrent tonsillitis : n = 4. **p < 0.01. Dashed bar means the upper 
limit of normal ranges (0.1 IU / ml).
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DISCUSSION
PFAPA syndrome is an autoinflammatory disease, which 
is caused by dysfunction of inflammasome (3). Inflammasome 
is a cytosolic protein complex of the innate immune system 
responsible for the activation of inflammatory responses in the 
macrophages and dendritic cells. Inflammasome activation is 
initiated by pattern recognition receptors that respond to foreign 
pathogen-related molecules, and the activated caspase-1 finally 
causes the production of inflammatory cytokines (11). Because it 
is suggested that PFAPA syndrome is a complex genetic disorder 
of proteins related to inflammasome, PFAPA syndrome is char-
acterized by a cytokine dysfunction, including the production 
of pro-inflammatory cytokines (12). In the present study, the 
serum levels of IL-6, a pro-inflammatory cytokine were in-
creased during febrile episodes in pediatric patients with PFAPA 
syndrome. It was also reported that the serum levels of IL-6 
were elevated in patients with PFAPA syndrome during febrile 
episodes, compared to those in remission or to controls (6, 7). 
However, in the present study, the serum levels of IL-6 were also 
increased in febrile patients with recurrent tonsillitis, because of 
production of IL-6 during acute infection in response to bacterial 
or viral infections (13). Chen et al. also reported that in children 
with hematological disorders, blood levels of IL-6 were elevated 
by bacterial infection (14). Therefore, it is suggested that the 
increased levels of IL-6 in the blood during a high fever are not 
helpful in the differential diagnosis of PFAPA syndrome from 
acute infection of recurrent tonsillitis in children. 
In the present study, the mean serum levels of IL-4 during 
febrile episodes in pediatric patients with recurrent tonsillitis 
were significantly higher than those in patients with PFAPA 
syndrome. It was reported that IL-4 in the blood is increased in 
anti-inflammatory responses to the activation of pro-inflamma-
tory cytokine such as IL-6 during bacterial or viral infection (15, 
16). In fact, Yusa et al. reported that both IL-6 and IL-4 levels 
were elevated in children with bacterial infection (17). On the 
contrary, Stojanov et al. reported that the serum levels of IL-4 
did not increase during a febrile episode in PFAPA syndrome 
patients, compared with controls (6). It was assumed that a 
continuous pro-inflammatory cytokine activation with a reduced 
anti-inflammatory cytokine response is due to the dysregulation 
of immune response in PFAPA syndrome (6). Therefore, it is 
suggested that the suppressed blood levels of IL-4 despite an 
increase of IL-6 can differentiate PFAPA syndrome from acute 
infection of recurrent tonsillitis in children. 
The present study showed a marked increase in serum levels 
of IFN-γ during high fever in pediatric patients with PFAPA 
syndrome, but not in pediatric patients with recurrent tonsillitis. 
In fact, in patients with PFAPA syndrome, the increased levels 
of IFN-γ in the blood was also reported during a febrile episode, 
compared to remission period or to controls (6, 7). Because IFN-γ 
suppresses the production of IL-4 (18, 19), its increase in patients 
with PFAPA syndrome is thought to be responsible for the sup-
pressed levels of IL-4 in these patients. Although febrile attacks 
are followed by anti-inflammatory cytokine response to avoid 
exacerbating inflammation under physiological conditions, over-
production of IFN-γ due to dysfunction of inflammasome (20) 
suppressed the increase of anti-inflammatory cytokines such as 
IL-4, leading to persistent inflammation in patients with PFAPA 
syndrome. Therefore, it is suggested that IFN-γ plays a key role 
in continuing pro-inflammatory cytokine activation with its sup-
pressing anti-inflammatory response in patients with PFAPA 
syndrome. On the contrary, as shown in patients with recurrent 
tonsillitis of the present study, levels of IFN-γ in the blood were 
around the upper limit of normal ranges during febrile episode. 
It was also reported that in children with hematological disorders, 
IFN-γ in the blood was not elevated by bacterial infection (11). 
All these present findings suggested that the characteristic 
cytokine profiles in the blood during high fever that despite an 
increase of IL-6, a suppression of IL-4 with a marked increase of 
IFN-γ in patients with PFAPA are helpful for differential diag-
nosis from recurrent tonsillitis in children. 
Patients with PFAPA syndrome show elevated values of WBC 
and CRP during typical episodes of fever (5). But, leukocytosis is 
also found in most febrile episodes in children, like in acute ton-
sillitis. CRP is an acute phase protein and its high levels during 
febrile episodes are also observed in bacterial infection or other 
inflammatory disease in children. In the present study, elevated 
values of WBC and CRP during febrile episodes are observed in 
children with both PFAPA syndrome and recurrent tonsillitis. 
In conclusion, the present findings showed that in patients 
with PFAPA syndrome, despite an increase of IL-6, IL-4 was 
suppressed under upper limit of normal ranges with a marked 
increase of IFN-γ in the blood during a febrile episode. On 
the contrary, in patients with recurrent tonsillitis, both IL-6 
and IL-4, but not IFN-γ in the blood were increased during fe-
brile episode. The characteristic cytokine profiles of continuous 
pro-inflammatory cytokine activation with a reduced anti-in-
flammatory cytokine response leads to sustained inflammation 
in patients with PFAPA syndrome. Taken together, the findings 
of the present study suggest that the characteristic cytokine 
profiles of IL-6, IL-4 and IFN-γ can be the differential features 
between PFAPA syndrome and recurrent tonsillitis in children 
in clinical ENT settings.
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